NO914250D0 - Fremgangsmaate for fremstilling av piperazinderivater - Google Patents

Fremgangsmaate for fremstilling av piperazinderivater

Info

Publication number
NO914250D0
NO914250D0 NO914250A NO914250A NO914250D0 NO 914250 D0 NO914250 D0 NO 914250D0 NO 914250 A NO914250 A NO 914250A NO 914250 A NO914250 A NO 914250A NO 914250 D0 NO914250 D0 NO 914250D0
Authority
NO
Norway
Prior art keywords
procedure
piperazine derivatives
preparing piperazine
preparing
derivatives
Prior art date
Application number
NO914250A
Other languages
English (en)
Other versions
NO914250L (no
Inventor
Eva Agai
Tibor Gizur
Kalman Harsanyi
Ferenc Trischler
Aniko Demeter
Attila Csehi
Eva Vajda
Gyoergyi Szabo
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO914250D0 publication Critical patent/NO914250D0/no
Publication of NO914250L publication Critical patent/NO914250L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO91914250A 1990-10-31 1991-10-30 Fremgangsmaate for fremstilling av piperazinderivater NO914250L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU906953A HU209723B (en) 1990-10-31 1990-10-31 Process for producing of piperazine derivatives

Publications (2)

Publication Number Publication Date
NO914250D0 true NO914250D0 (no) 1991-10-30
NO914250L NO914250L (no) 1992-05-04

Family

ID=10972063

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914250A NO914250L (no) 1990-10-31 1991-10-30 Fremgangsmaate for fremstilling av piperazinderivater

Country Status (11)

Country Link
EP (1) EP0483932A1 (no)
JP (1) JPH04264078A (no)
KR (1) KR920008018A (no)
AU (1) AU8683091A (no)
CA (1) CA2054544A1 (no)
CS (1) CS329491A3 (no)
HU (1) HU209723B (no)
NO (1) NO914250L (no)
PL (1) PL292227A1 (no)
PT (1) PT99368A (no)
ZA (1) ZA918636B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0585500A1 (en) * 1992-09-04 1994-03-09 Merrell Dow Pharmaceuticals Inc. Diaryl piperazineacetamides as antimuscarinic agents
AU2001239827A1 (en) 2000-02-22 2001-09-03 Cv Therapeutics, Inc. Substituted alkylene diamine compounds
US6552023B2 (en) 2000-02-22 2003-04-22 Cv Therapeutics, Inc. Aralkyl substituted piperazine compounds
US6677336B2 (en) 2000-02-22 2004-01-13 Cv Therapeutics, Inc. Substituted piperazine compounds
WO2001062749A1 (en) 2000-02-22 2001-08-30 Cv Therapeutics, Inc. Substituted piperazine compounds
US6451798B2 (en) 2000-02-22 2002-09-17 Cv Therapeutics, Inc. Substituted alkyl piperazine derivatives
EP1259493A2 (en) * 2000-02-22 2002-11-27 Cv Therapeutics, Inc. Substituted piperazine compounds
KR100797835B1 (ko) * 2001-08-13 2008-01-24 주식회사 포스코 핀치롤의 이물질 제거장치
AU2003303676A1 (en) 2003-01-03 2004-08-10 Gilead Palo Alto, Inc. Substituted heterocyclic compounds
JP2007518677A (ja) 2003-06-23 2007-07-12 シーブイ・セラピューティクス・インコーポレイテッド 脂肪酸酸化インヒビターとしてのピペラジンおよびピペリジンのウレア誘導体
AU2004303882A1 (en) * 2003-12-18 2005-07-07 Gilead Palo Alto, Inc. 1-akan-2-ol substituted piperazine and piperidine compounds
WO2006008753A1 (en) * 2004-07-19 2006-01-26 Unichem Laboratories Limited Crystalline and amorphous form of ranolazine and the process for manufacturing them
WO2008047388A2 (en) * 2006-10-20 2008-04-24 Ind-Swift Laboratories Limited Improved process for the preparation of ranolazine
WO2008139492A2 (en) * 2007-05-15 2008-11-20 Natco Pharma Limited A process for the preparation of highly pure ranolazine base
WO2010029436A2 (en) * 2008-09-09 2010-03-18 Actavis Group Ptc Ehf Novel solid state forms of ranolazine salts
WO2010043976A2 (en) * 2008-10-15 2010-04-22 Actavis Group Ptc Ehf Highly pure ranolazine or a pharmaceutically acceptable salt thereof
WO2010097805A1 (en) 2009-02-24 2010-09-02 Lupin Limited A process for the preparation of ranolazine
EP3233814A4 (en) 2015-03-10 2018-07-18 Unichem Laboratories Limited Novel process for the preparation of ranolazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB662283A (en) * 1948-08-02 1951-12-05 Rhone Poulenc Sa Improvements in or relating to piperazine compounds
US4567264A (en) * 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry

Also Published As

Publication number Publication date
JPH04264078A (ja) 1992-09-18
ZA918636B (en) 1992-08-26
PL292227A1 (en) 1992-06-26
EP0483932A1 (en) 1992-05-06
KR920008018A (ko) 1992-05-27
HU209723B (en) 1994-10-28
CS329491A3 (en) 1992-05-13
PT99368A (pt) 1992-09-30
NO914250L (no) 1992-05-04
HU906953D0 (en) 1991-05-28
CA2054544A1 (en) 1992-05-01
AU8683091A (en) 1992-05-07
HUT62278A (en) 1993-04-28

Similar Documents

Publication Publication Date Title
NO913234L (no) Fremgangsmaate for fremstilling av pyrazolderivater.
DE69119329D1 (de) Actinonin-Derivate
NO914250L (no) Fremgangsmaate for fremstilling av piperazinderivater
DE69125099D1 (de) Indolderivate
ATE144765T1 (de) Hiv-hemmende benzenacetamidderivate
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
ATE171449T1 (de) Oxadolderivate
NO920965D0 (no) Fremgangsmaate for fremstilling av etylen-alfa-olefinkopolymerer
NO924028L (no) Forbedret fremgangsmaate for fremstilling av substituerte indolonderivater
NO901070L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO914056D0 (no) Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat
DK91890D0 (da) Piperazin-derivater
GB2248837B (en) Piperazine derivatives
NO914053L (no) Fremgangsmaate for fremstilling av 8-klorokinolonderivater
NO901071D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO912980D0 (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater
NO893713D0 (no) Fremgangsmaate for fremstilling av benzoksazolon-derivater.
NO925007L (no) Fremgangsmaate for fremstilling av benzofuranylimidazolderivater
NO914985D0 (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
NO911672D0 (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO914452L (no) Fremgangsmaate for fremstilling av isokinolinderivater
NO901069D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO901812L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO923481D0 (no) Fremgangsmaate for fremstilling av 1-hydroksyalkyl-5-nitroimidazol
FI944968A0 (fi) Menetelmä sakkariinijohdannaisten valmistamiseksi